Normal TSH with Low FT4 and Hypokalemia: Evaluation and Management
This presentation suggests central hypothyroidism (hypopituitarism) until proven otherwise, and the hypokalemia may indicate concurrent adrenal insufficiency—a life-threatening combination requiring immediate evaluation of the entire hypothalamic-pituitary axis before initiating any thyroid hormone replacement.
Immediate Diagnostic Priority
The combination of normal TSH with low FT4 is pathognomonic for central hypothyroidism (secondary or tertiary hypothyroidism due to pituitary or hypothalamic dysfunction) 1. This is not primary thyroid disease—the pituitary is failing to appropriately elevate TSH despite low thyroid hormone levels.
Critical Safety Concern: Rule Out Adrenal Insufficiency FIRST
Before initiating any thyroid hormone replacement, you must evaluate for concurrent adrenal insufficiency. The presence of hypokalemia raises significant concern for this, as hypopituitarism commonly affects multiple axes 1.
Why this matters for mortality: If you replace thyroid hormone when cortisol is low, the increased cortisol metabolism can precipitate an adrenal crisis—a potentially fatal complication 1. Hypokalemia can occur in adrenal insufficiency and would worsen acutely with thyroid replacement if cortisol is not repleted first.
Algorithmic Approach to Evaluation
Step 1: Morning Cortisol and ACTH (8 AM)
- Draw morning cortisol (8 AM) with simultaneous ACTH 2, 3
- Cortisol <138 nmol/L (5 μg/dL) with low/normal ACTH (<15 pg/mL) = secondary adrenal insufficiency
- Cortisol >500 nmol/L (18 μg/dL) = excludes adrenal insufficiency
- Cortisol 138-500 nmol/L = perform 250 μg cosyntropin stimulation test; peak cortisol <500 nmol/L at 30 or 60 minutes confirms diagnosis 2, 3
Step 2: Evaluate for Hypophysitis/Panhypopituitarism
Given central hypothyroidism is confirmed, assess other pituitary axes 4:
- Gonadal axis: LH, FSH, testosterone (males) or estradiol (premenopausal females)
- Growth hormone axis: IGF-1 (though GH stimulation testing may be needed)
- Posterior pituitary: Serum and urine osmolality if polyuria present (diabetes insipidus)
- Prolactin level to exclude mass effect
Step 3: Imaging
- MRI brain with pituitary protocol (with or without contrast) to evaluate for:
- Pituitary mass/adenoma
- Hypophysitis (especially if on immune checkpoint inhibitors)
- Empty sella
- Structural abnormalities 4
Step 4: Address the Hypokalemia
While evaluating the endocrine axes, correct the hypokalemia:
- Measure serum potassium, magnesium, and assess acid-base status
- Replete potassium cautiously with cardiac monitoring
- Consider whether hypokalemia is from:
- Adrenal insufficiency (mineralocorticoid deficiency is rare in secondary AI but can occur)
- Concurrent illness/medications
- Note: Thyrotoxic periodic paralysis causes hypokalemia with HIGH thyroid hormones 5, which is the opposite of this presentation—so this is unlikely here
Management Algorithm
If Adrenal Insufficiency is Confirmed or Highly Suspected:
START HYDROCORTISONE FIRST, BEFORE THYROID HORMONE 1
Hydrocortisone 15-20 mg/day in divided doses:
- Highest dose in morning upon awakening
- Second dose in early afternoon (two-dose regimen)
- OR split into three doses: morning, lunch, late afternoon 2
Wait several days after starting hydrocortisone before initiating levothyroxine 4
Patient education is mandatory:
- Stress-dose protocols (double dose during illness)
- Emergency injectable glucocorticoid kit
- Medical alert bracelet for adrenal insufficiency 2
Thyroid Hormone Replacement (After Cortisol Replacement):
Levothyroxine dosing for central hypothyroidism:
- Age <70, no cardiac disease: Start full replacement ~1.6 mcg/kg/day based on ideal body weight 1
- Age >70 or cardiac disease/frailty: Start low at 25-50 mcg and titrate up 1
Monitoring is different than primary hypothyroidism:
- Monitor FT4 levels, NOT TSH 4, 6
- TSH remains unreliable in central hypothyroidism and will not normalize appropriately
- Target FT4 in the mid-to-upper normal range (studies show pituitary patients are often under-replaced when using lower-normal FT4 targets) 6
- Recheck FT4 every 6-8 weeks during titration 1
Endocrinology Consultation
Obtain endocrinology consultation urgently for:
- Confirmation of central hypothyroidism diagnosis
- Management of multiple pituitary hormone deficiencies
- Guidance on hormone replacement titration
- Long-term monitoring strategy 1
Common Pitfalls to Avoid
Never start levothyroxine before ruling out/treating adrenal insufficiency—this can trigger adrenal crisis 1
Do not use TSH to monitor therapy in central hypothyroidism—it will remain low/normal and is not a reliable marker 4, 6
Do not assume isolated central hypothyroidism—evaluate all pituitary axes as multiple deficiencies are common 1
Do not use fludrocortisone in secondary adrenal insufficiency—mineralocorticoid replacement is not needed as the renin-angiotensin system remains intact 2
Recognize that "normal" TSH with low FT4 is NEVER normal—this always requires investigation for central hypothyroidism or assay interference 1, 7